In Brief
This article was originally published in The Tan Sheet
Executive Summary
Ramirez appointed FTC chair; budget sequester slows FDA travel, training; ChromaDex divests BluScience brand; Omega Protein buys whey firm; Vitamin Shoppe absorbs integration costs; Vitacost trims net loss in Q4; chemical regulation champion Lautenberg to retire; USANA expands in China.
You may also be interested in...
Investor Taunts Omega Protein, Suggests Ripe Conditions For Sale
Wynnefield Capital, in an SEC filing, includes a letter it sent to Omega Protein noting M&A activity in the fish product market creates promising conditions for the firm’s sale. The group also makes candid observations about its lack of faith in Omega Protein’s management.
Investor Taunts Omega Protein, Suggests Ripe Conditions For Sale
Wynnefield Capital, in an SEC filing, includes a letter it sent to Omega Protein noting M&A activity in the fish product market creates promising conditions for the firm’s sale. The group also makes candid observations about its lack of faith in Omega Protein’s management.
Industry News Roundup
‘Heal yourself’ claim nicked by FDA; Urban Moonshine’s error of omission; new tech needs old school substantiation; O2 plans big for InboxFitness; Migranade sprouts spray division; ChromaDex cashes in NeutriSci shares; GoodSense sponsors runDisney; Walgreens joins flu tracking crowd; Qualitas algal omega-3 reaches market; Islet cooks cannabidoil in business plan; and Food Advisory Committee candidates sought.